Skip to main content
logo
Cyclerion Therapeutics, Inc. (CYCN)
23.52
-6.23 (-20.94%)
Inactive · Last trade price on Sep 8, 2026

Cyclerion Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.92.072-0.33.94
Revenue Growth
-12.60%3.70%---92.47%71.69%
Gross Profit
0.31.121.71-1.32-5.28-33.69
Operating Income
-6.82-4.97-3.63-9.65-18.54-54.31
Net Income
-6.71-3.53-3.06-5.26-44.08-51.65
Earnings Per Share
-1.73-1.11-1.21-2.25-20.28-26.39
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.393.243.237.5713.3853.96
Total Debt
------
Net Cash (Debt)
1.393.243.237.5713.3853.96
Net Cash Growth
-53.73%0.25%-57.31%-43.42%-75.20%523.11%
Net Cash Per Share
0.361.021.283.246.1627.57

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-4.45-3.31-4.33-21.25-40.61-36.52
Capital Expenditures
-0.07-----0.01
Free Cash Flow
-4.52-3.31-4.33-21.25-40.61-36.52
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
15.95%53.76%85.70%---
Operating Margin
-359.16%-239.78%-181.40%--6242.42%-1377.83%
Pretax Margin
-353.00%-170.11%-152.85%--6143.43%-1310.17%
Profit Margin
-353.00%-170.11%-152.85%--14841.08%-1310.17%
FCF Margin
-237.74%-159.79%-216.65%--13673.74%-926.53%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
8.152.334.08-96.1018.90